← Back to patent-cliff list
Verenafusp alfa
Tier C — Watch / tradeVerenafusp alfa
Generium Pharmaceuticals
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
-
Type
Targets：IDS
Indications (approved)：Ⅱ型黏多糖贮积症, 代谢病
Regional status
US
-
EU
Phase III
2021-11-30
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Verenafusp alfa?
Approved indications include: Ⅱ型黏多糖贮积症, 代谢病.
When does the Verenafusp alfa patent expire?
No public expiry year is available for Verenafusp alfa yet; this page updates once verified.
How do I get a quote for Verenafusp alfa intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21